- $9.12bn
- $17.15bn
- $5.34bn
Annual income statement for Lineage, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 3,702 | 4,928 | 5,342 | 5,340 |
| Cost of Revenue | ||||
| Gross Profit | 1,122 | 1,455 | 1,752 | 1,762 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 3,627 | 4,630 | 4,943 | 5,718 |
| Operating Profit | 75.2 | 299 | 398 | -378 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -214 | -70 | -110 | -840 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -187 | -76 | -96.2 | -751 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -164 | -62.7 | -77.4 | -664 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -164 | -62.7 | -77.4 | -664 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.259 | -0.048 | -0.081 | -0.866 |
| Dividends per Share |